Ведение пациентов с диабетической полиневропатией: современные рекомендации по диагностике и лечению, возможности фармакотерапии
https://doi.org/10.21518/2079-701X-2015-18-24-29
Аннотация
Об авторах
В. А. ГоловачеваРоссия
В. А. Парфенов
Россия
Список литературы
1. Boulton AJM, Malik RA, Arezzo J et al. Diabetic somatic neuropathies. Diabetic Care, 2004. 27: 1458-1486.
2. Soedamah-Muthu SS, Chaturvedi N, Witte DR et al.; EURODIAB Prospective Complications Study Group. Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complication Study (PCS). Diabetes Care, 2008; 37 (7): 1360-1366.
3. Carrington AL, Shaw JE, Van Schie CMH et al. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care, 2002; 25: 2010-2015.
4. Frykberg RG, Zgonis T, Armstrong DC et al. Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg, 2006; 45 (5): 1-66.
5. Abbot CA, Malik RA, van Ross ER et al. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care, 2011; 34: 2220-2224.
6. Ziegler D, Rathmann W, Dickhaus T et al. KORA Study Group. Neuropathic pain in diabetes, pre-diabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3. Pain Med, 2009; 10: 393-400.
7. Young LH, Wackers FJ, Chyun DA et al. DIAD Investigator. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA, 2009; 301: 1547-1555.
8. Thomas PK. Classification, differential diagnosis and staging of diabetic peripheral neuropathy. Diabetes, 1997; 46; Suppl. 2:54-57.
9. Boulton AJ, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care, 2005; 28: 956-962.
10. Tesfaye S, Boulton AJM, Dyck PJ et al. Diabetic Neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments on behalf of the Toronto Diabetic Neuropathy Expert Group. Diabetes Care, 2010; 33: 2285-2293.
11. Kasznicki J. Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy. Arch Med Sci, 2014; 10(2): 345-354.
12. Строков И.А., Фокина А.С., Строков К.И. и др. Современные принципы диагностики и лечения диабетической полинейропатии. Медицинский совет, 2014; 5:38-42.
13. Строков И.А., Зилов А.В., Фокина А.А. Диабетическая кардиальная автономная невропатия. Лечебное дело, 2013; 1:49-54.
14. Vinik AI, Maser RE, Mitchell BD et al. Diabetic autonomic neuropathy. Diabetes Care, 2003; 26(5): 1553-1579.
15. Van Deuresen RW, Sanchez MM, Ulbrecht JS et al. The role of muscle spindles in ankle movement perception in human subjects with diabetic neuropathy. Exp Brain Res, 1998; 120:1-8.
16. Ziegler D. Современные принципы ведения больных с диабетической полинейропатией. Нервно-мышечные болезни, 2012; 2: 7-19.
17. Malik RA, Kallinikos P, Abbot CA et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia, 2003; 46:683-688.
18. Edwards K, Pritchard N, Vagenas D et al. Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study. Clin Exp Optom, 2012; 95:348-354.
19. Dyck PJ, Kratz JL et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in population-based cohort Rochester Diabetic Neuropathy Study Neuropathy Study. Neurology, 1993; 43: 817-824.
20. Tesfaye S, Vileikyte L, Rayman G et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev, 2011; 27:629-638.
21. Строков И.А. Место нейротропных комплексов в терапии неврологических осложнений сахарного диабета. РМЖ, 2013; 30: 1535-1539.
22. Строков И.А., Фокина А.С. Головачева В.А. и др. Альфа-липоевая кислота в лечении диабетической полиневропатии. Эффективная фармакотерапия, 2013; 1:50-54.
23. Ziegler D, Nowak H, Kempler P et al. Treatment of symptomatic diabetic polyneuropathy with alpha-lipoic acid: a meta-analysis. Diabetic Med., 2004; 21:114-121.
24. Han T, Bai J, Liu W et al. A systematic review and meta-analysis of a-lipoic acid in the treatment of diabetic peripheral neuropathy. European Journal of Endocrinology, 2012; 167: 465-471.
25. Зиновьева О.Е. Антиоксидантная терапия в лечении диабетической и алкогольной полиневропатии. Consilium medicum, 2006; 8: 120-124.
Рецензия
Для цитирования:
Головачева В.А., Парфенов В.А. Ведение пациентов с диабетической полиневропатией: современные рекомендации по диагностике и лечению, возможности фармакотерапии. Медицинский Совет. 2015;(18):24-29. https://doi.org/10.21518/2079-701X-2015-18-24-29
For citation:
Golovacheva V.A., Parfyonov V.A. Management of patients with diabetic polyneuropathy: current guidelines for diagnosis and treatment, prospects for pharmacotherapy. Meditsinskiy sovet = Medical Council. 2015;(18):24-29. (In Russ.) https://doi.org/10.21518/2079-701X-2015-18-24-29